Trade Pharming Group N.V. - PHAR CFD

Add to favourite

0.868

0.12%

0.007

Low: 0.862

High: 0.879

Market Trading Hours* (UTC) Opens on Monday at 08:00

Mon - Fri: 08:00 - 16:30

Summary
Historical Data

Trading сonditions

Spread

0.007

Long position overnight fee

-0.018641%

Short position overnight fee

-0.003582%

Overnight fee time

22:00 (UTC)

Min traded quantity

Currency

EUR

Margin

5.00%

Stock exchange

Netherlands

Commission on trade

Key Stats

Prev. Close	0.869
Open	0.876
1-Year Change	-13.86%
Day's Range	0.862 - 0.879

Last Week
Last Month
Last Year
Last two Years
Max

Daily
Weekly
Monthly

Date	Close	Change	Change (%)	Open	High	Low
Feb 20, 2025	0.869	0.010	1.16%	0.859	0.875	0.852
Feb 19, 2025	0.873	-0.009	-1.02%	0.882	0.886	0.872
Feb 18, 2025	0.886	0.008	0.91%	0.878	0.901	0.857
Feb 17, 2025	0.876	0.025	2.94%	0.851	0.876	0.841
Feb 14, 2025	0.849	-0.001	-0.12%	0.850	0.867	0.839
Feb 13, 2025	0.849	0.012	1.43%	0.837	0.850	0.825
Feb 12, 2025	0.839	0.016	1.94%	0.823	0.848	0.823
Feb 11, 2025	0.841	0.008	0.96%	0.833	0.853	0.826
Feb 10, 2025	0.833	0.007	0.85%	0.826	0.841	0.815
Feb 7, 2025	0.827	-0.002	-0.24%	0.829	0.841	0.821
Feb 6, 2025	0.836	0.002	0.24%	0.834	0.847	0.831
Feb 5, 2025	0.835	0.014	1.71%	0.821	0.836	0.813
Feb 4, 2025	0.824	0.000	0.00%	0.824	0.835	0.822
Feb 3, 2025	0.834	-0.011	-1.30%	0.845	0.854	0.818
Jan 31, 2025	0.861	0.005	0.58%	0.856	0.866	0.855
Jan 30, 2025	0.864	0.013	1.53%	0.851	0.868	0.841
Jan 29, 2025	0.849	0.006	0.71%	0.843	0.873	0.841
Jan 28, 2025	0.856	0.016	1.90%	0.840	0.869	0.838
Jan 27, 2025	0.856	0.007	0.82%	0.849	0.866	0.836
Jan 24, 2025	0.869	-0.001	-0.11%	0.870	0.884	0.855

Trading calculator

Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).

Trade commission

1:1
2:1
3:1
5:1
10:1
20:1

Leverage

20:1

20
100
500
1000
10000

Investment

Trade size (Leverage x Investement):

Open

Close

Short Long

For the avoidance of doubt, this calculation does not include the costs of holding a position overnight (for which there will be additional charges)

Pharming Group Company profile

About Pharming Group N.V.

Pharming Group NV is a biopharmaceutical company based in the Netherlands. The Company is engaged in the development, production and commercialization of human therapeutic proteins to be used in the therapies. The Company's product portfolio is aimed at treatments for genetic disorders, blood-related disorders, infectious and inflammatory diseases, tissue and bone damage and surgical/traumatic bleeding. Its core product, RUCONEST (conestat alfa) is a recombinant human C1 esterase inhibitor approved for the treatment of acute Hereditary Angioedema (HAE) attacks in patients in Europe, the Unites States, Israel and South Korea. The product is available on a named-patient basis in other territories where it has not yet obtained marketing authorization.

Financial summary

BRIEF: For the fiscal year ended 31 December 2021, Pharming Group N.V. revenues decreased 10% to EUR167.7M. Net income decreased 59% to EUR13.5M. Revenues reflect a decrease in demand for the Company's products and services due to unfavorable market conditions. Net income also reflects Research and development increase of 76% to EUR59.3M (expense), General and administrative increase of 48% to EUR31.2M (expense).

Equity composition

4/2010, Nominal value changed from EUR 0.5. 07/2012, Nominal value changed from EUR0.04. 3/2013, 1-for-10 reverse stock split (Factor: 0.1 ). 3/2013, Nominal value changed from EUR0.1 to EUR0.01. 11/2016, Rights Issue, 1 new share for every 7 shares held @ 0.205EUR, (Factor: 1.00751).

Industry:

Pharmaceuticals (NEC)

Darwinweg 24
LEIDEN
ZUID-HOLLAND 2333 CR
NL

News

Microsoft Stock Price Forecast for 2025 and beyond: Third party price target

We assess the likely level of the Microsoft stock price in 5 years, and possible drivers behind the stock’s past performance. Read on...

18:29, 7 February 2025

Ripple XRP price prediction: Third-party price target

Discover the ripple (XRP) price predictions for 2025 and beyond, with analyst price targets and CFDs trading strategies on Capital.com

15:29, 6 February 2025

Apple Store on Fifth Avenue, New York, October 2016

Apple (AAPL) stock price forecast: third-party price target

We looked at the forecasts for Apple stock in 10 years to see where the price would likely be at that point and the challenges the company could face. Read more.

11:22, 6 February 2025